BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 23855591)

  • 1. Cervical dystonia: effectiveness of a standardized physical therapy program; study design and protocol of a single blind randomized controlled trial.
    van den Dool J; Visser B; Koelman JH; Engelbert RH; Tijssen MA
    BMC Neurol; 2013 Jul; 13():85. PubMed ID: 23855591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Botulinum toxin type B for cervical dystonia.
    Costa J; Espírito-Santo C; Borges A; Ferreira JJ; Coelho M; Moore P; Sampaio C
    Cochrane Database Syst Rev; 2005 Jan; (1):CD004315. PubMed ID: 15674941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-Term Specialized Physical Therapy in Cervical Dystonia: Outcomes of a Randomized Controlled Trial.
    van den Dool J; Visser B; Koelman JH; Engelbert RH; Tijssen MA
    Arch Phys Med Rehabil; 2019 Aug; 100(8):1417-1425. PubMed ID: 30796919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants of disability in cervical dystonia.
    van den Dool J; Tijssen MA; Koelman JH; Engelbert RH; Visser B
    Parkinsonism Relat Disord; 2016 Nov; 32():48-53. PubMed ID: 27553512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study protocol: multimodal physiotherapy as an add-on treatment to botulinum neurotoxin type A therapy for patients with cervical dystonia: DysPT-multi-a prospective, multicentre, single-blind, randomized, controlled study.
    Werner C; Loudovici-Krug D; Derlien S; Rakers F; Smolenski UC; Lehmann T; Best N; Günther A
    Trials; 2021 Oct; 22(1):740. PubMed ID: 34696821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome of selective ramisectomy for botulinum toxin resistant torticollis.
    Ford B; Louis ED; Greene P; Fahn S
    J Neurol Neurosurg Psychiatry; 1998 Oct; 65(4):472-8. PubMed ID: 9771768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Botulinum toxin B: a review of its therapeutic potential in the management of cervical dystonia.
    Figgitt DP; Noble S
    Drugs; 2002; 62(4):705-22. PubMed ID: 11893235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Botulinum toxin type B: a double-blind, placebo-controlled, safety and efficacy study in cervical dystonia.
    Lew MF; Adornato BT; Duane DD; Dykstra DD; Factor SA; Massey JM; Brin MF; Jankovic J; Rodnitzky RL; Singer C; Swenson MR; Tarsy D; Murray JJ; Koller M; Wallace JD
    Neurology; 1997 Sep; 49(3):701-7. PubMed ID: 9305326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Botulinum toxin treatment of axial and cervical dystonia.
    Benecke R; Dressler D
    Disabil Rehabil; 2007 Dec; 29(23):1769-77. PubMed ID: 18033602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cervical dystonia and quality of life.
    Tomic S; Petkovic I; Pucic T; Resan B; Juric S; Rotim T
    Acta Neurol Belg; 2016 Dec; 116(4):589-592. PubMed ID: 27138215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Botulinum toxin type B vs. type A in toxin-naïve patients with cervical dystonia: Randomized, double-blind, noninferiority trial.
    Pappert EJ; Germanson T;
    Mov Disord; 2008 Mar; 23(4):510-7. PubMed ID: 18098274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Botulinum toxin type A therapy for cervical dystonia.
    Castelão M; Marques RE; Duarte GS; Rodrigues FB; Ferreira J; Sampaio C; Moore AP; Costa J
    Cochrane Database Syst Rev; 2017 Dec; 12(12):CD003633. PubMed ID: 29230798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized study of botulinum toxin versus botulinum toxin plus physical therapy for treatment of cervical dystonia.
    Hu W; Rundle-Gonzalez V; Kulkarni SJ; Martinez-Ramirez D; Almeida L; Okun MS; Wagle Shukla A
    Parkinsonism Relat Disord; 2019 Jun; 63():195-198. PubMed ID: 30837195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Muscle selection for treatment of cervical dystonia with botulinum toxin--a systematic review.
    Nijmeijer SW; Koelman JH; Kamphuis DJ; Tijssen MA
    Parkinsonism Relat Disord; 2012 Jul; 18(6):731-6. PubMed ID: 22575237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BotB (botulinum toxin type B): evaluation of safety and tolerability in botulinum toxin type A-resistant cervical dystonia patients (preliminary study).
    Truong DD; Cullis PA; O'Brien CF; Koller M; Villegas TP; Wallace JD
    Mov Disord; 1997 Sep; 12(5):772-5. PubMed ID: 9380065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Botulinum toxin therapy for cervical dystonia.
    Walker FO
    Phys Med Rehabil Clin N Am; 2003 Nov; 14(4):749-66, vi. PubMed ID: 14580035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized trial of specialized versus standard neck physiotherapy in cervical dystonia.
    Counsell C; Sinclair H; Fowlie J; Tyrrell E; Derry N; Meager P; Norrie J; Grosset D
    Parkinsonism Relat Disord; 2016 Feb; 23():72-9. PubMed ID: 26723272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pallidal neurostimulation versus botulinum toxin injections in the treatment of cervical dystonia: protocol of a randomized, sham-controlled trial (StimTox-CD).
    Odorfer TM; Malzahn U; Matthies C; Heuschmann PU; Volkmann J
    Neurol Res Pract; 2019; 1():2. PubMed ID: 33324868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RimabotulinumtoxinB effects on pain associated with cervical dystonia: results of placebo and comparator-controlled studies.
    Lew MF; Chinnapongse R; Zhang Y; Corliss M
    Int J Neurosci; 2010 Apr; 120(4):298-300. PubMed ID: 20374078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concurrent onabotulinumtoxinA treatment of cervical dystonia and concomitant migraine.
    Winner PK; Sadowsky CH; Martinez WC; Zuniga JA; Poulette A
    Headache; 2012 Sep; 52(8):1219-25. PubMed ID: 22607530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.